Wednesday, 6 May 2020

Advanced Analytics in Commercial Pharmaceutical Market: Demand, Overview, Price And Business Opportunities

Commercial Pharmaceutical Analytics Market – Overview
The integration of technology in managing and optimizing the service delivery of the health care sector is expected to enhance the commercial pharmaceutical analytics market positively. Reports that review the healthcare IT industry has been offered by Market Research Future, which generates reports on industry verticals that evaluate the market development and opportunities.  The Advanced analytics in commercial pharmaceutical industry is anticipated to utilize a 20.0% CAGR in the duration of the forecast period.

The use of analytics is expected to motivate the development of the pharmaceutical sector increasingly. The pharmaceuticals sector is charged with the creation of effective drugs that can be used to treat a wide spectrum of diseases. The increased degree of sophistication in the pharma sector is anticipated to push the growth of the commercial pharmaceutical analytics market in the coming years.

Commercial Pharmaceutical Analytics Market Segmental Analysis
The segmentation of the commercial pharmaceutical analytics market has been carried out on the basis of types, deployment, application, and regions. Based on the types, the commercial pharmaceutical analytics market comprises of descriptive analytics, prescriptive analytics, and predictive analytics. The segmentation of the commercial pharmaceutical analytics market based on deployment comprises of web-based and cloud-based. Based on applications, the commercial pharmaceutical analytics market is segmented into marketing & sales, R&D, internal reporting, supply chain optimizations, and others. Based on regions, the commercial pharmaceutical analytics market is segmented into the Americas, Europe, Asia Pacific, Africa, and the Middle East.

Commercial Pharmaceutical Analytics Market Regional Analysis   
The regional assessment of the commercial pharmaceutical analytics market includes regions such as the Americas, Europe, Asia Pacific, Africa, and the Middle East. As per the analysis, the North American region is the major regional market for the commercial pharmaceutical analytics market. The European region is the subsequent principal market for the commercial pharmaceutical analytics market globally. The market is projected to touch at revenues worth USD 2,613.1 by 2027. Due to the growing adoption rate, the Asia Pacific region is projected to be the fastest rising region globally, recording a 20.8% CAGR throughout the forecast period.

Commercial Pharmaceutical Analytics Market Competitive Analysis
The market is ushering in a phase of development that is expected to be motivated by the positive factors in the market. The strategies in the market are being aimed at improving the overall progress of the market, with the business models taking into account all contingencies that may arise in the coming years. The profitability in the market is enhanced significantly by the existence of strong strategies deployed by market players. The identification and use of apposite media channels are expected to transform the market development in the coming years. The pull created by the businesses in the market by positioning marketing policies and events is additionally growing the development of the market. The improvement of production resources is likely to stimulate the market’s improvement in the forecast period. The demographics present in the market present a favorable outlook in terms of product expansion and future growth potential.


The eminent contenders in the commercial pharmaceutical analytics market are Microsoft (U.S), Wipro Limited (U.S), Statistical Analysis System (U.S), Allscripts (U.S), Scio Health Analytics (U.S),International Business Machines Corporation (U.S), ORACLE (U.S), Citiustech INC (U.S), Take Solutions LTD (U.S), Trinity Pharma Solutions (U.S), Fuzzy Logix INC (U.S), Northwest Analytics, INC. (U.S), and Cerner Corporation (U.S)
Posted by at 1 comment:
Labels:

Veterinary CBD Market 2020 To 2025 Booming Trends, Share, Growth Challenges, Key Players And Industry Segments

The legalization of cannabis in certain nations ha saved numerous lives. With the rise in pet ownership numbers and pet healthcare costing a heft amount, cannabidiol (CBD) plays a major part in alleviating the pain of pets. The global veterinary CBD market report by Market Research Future (MRFR) contains numerous insights and trends which would provide investors in making wise decisions.

Veterinary CBD Market Outlook
The global veterinary CBD market is poised to reach a stellar mark by 2025. It can exhibit a CAGR of 129% from 2019 to 2025 (forecast period). It stood at USD 98.83 million in 2018. The rise in the number of pet owners combined with the inclination of pet owners to spend money on animal health are likely to drive the market growth till 2025. High prevalence of mental health as well as pain caused by diseases among pets can drive the market demand at an exponential rate.

Clinical trials outlining the effectiveness of CBD-infused products are likely to gather support for the veterinary CBD market till the end of the forecast period. A study published in the National Center for Biotechnology Information (NCBI) in 2019 has found CBD given to dogs suffering from epilepsy had fewer epileptic attacks. CBD oil given to pets have been known to alleviate pain levels and provide soothing effects for anxiety and other maladies.
The preference for organic foods by pet owners over conventional due to their taste, flavor, and low probability of side-effects can bode well for the market prospects in the coming years. The high market valuation pegged for the pet care market at USD 202.6 billion by 2025 is a positive indicator of the large size predicted for the global veterinary CBD market.

Unclear laws and legalizations pertaining to Veterinary CBD products can impinge the market growth.

Veterinary CBD Market Segmentation Analysis
The global veterinary CBD market is segmented by source, product, and distribution channel.
By source, it is segmented into hemp derived and marijuana derived. The hemp derived segment is expected to perform exceptionally due to being a source of tetrahydrocannabinol (THC) and the unclear policies regarding marijuana. On the other hand, the marijuana derived segment can drive the fortunes of the global veterinary CBD market due to the legalization of marijuana farming in few countries.

By product, it is segmented into therapeutic-grade, food-grade, and personal care. Therapeutic-grade is further segmented into pet supplements and pet CBD oils. Food-grade, on the other hand, is segmented into soft chews, treats, and others. The therapeutic-grade segment is projected to exhibit a stellar growth rate during the forecast period due to rollback of certain policies restricting production of CBD. On the flip side, the personal care segment is expected to expand in size due to opportunities for mood management and elderly pet care.

By distribution channel, it is segmented into veterinary clinics, retail pharmacies, e-commerce websites, and others.

Veterinary CBD Market Regional Analysis
Asia Pacific (APAC), the Americas, the Middle East & Africa (MEA), and Europe are regions taken into consideration in the compilation of the global veterinary CBD market report.
The Americas is likely to generate a significant amount of revenue for the global market due to the passing of the 2018 Agricultural Improvement Act which has approved the legalization of marijuana farming. Within the Americas, North America can contribute to the global veterinary CBD due to supportive pet-friendly policies. Latin America has a smaller share compared to its counterpart owing to low infrastructure. But allocation of land in Uruguay as well as policies encouraging growth of hemp can drive the regional growth.

The APAC region has promise for massive growth due to being one of the biggest cultivators of medical marijuana. Higher awareness of CBD is likely to drive the demand of the market in the coming years.


Veterinary CBD Market Competitive Analysis
Major industry participants in the global veterinary CBD market include Joy Organics, Fomo Bones, Green Roads of Florida, LLC, HempMy Pet, Honest Paws, Pet Releaf, Wet Noses, Canna-Pet, and HolistaPet.

Veterinary CBD Industry News
Willie’s Reserve, a U.S. based chain of stores offering marijuana-based products, is launching a new line exclusively for pets. The company is willing to reach its consumer by showcasing its line at pet product exhibitions.
Posted by at No comments:
Labels:

Pemphigus Vulgaris (PV) Treatment Market Key Strategies, Historical Analysis, Segmentation, Application, Technology, Trends And Opportunities

Pemphigus Vulgaris Market Overview:
Pemphigus vulgaris, an autoimmune disease, is quite common in the US. This causes painful lesions on the mucous membranes. The disease affects neck, face, scalp, and back, sometimes it spreads even further to the armpits and the genitalia. The lesion can join up with each other and can make a much more severe attack on the face. This will make swallowing things difficult. The global pemphigus vulgaris market is expected to reach a valuation of USD 677.99 million by 2027 at an 8% CAGR during the forecast period (2018-2027). Market Research Future (MRFR), in their recently revealed Pemphigus Vulgaris (PV) Treatment Market Report, claims that its factors are going to play an assertive role for the furtherance of the pemphigus vulgaris market.

Factors like advancement in medicine is expected to take the market forward. Also, robust healthcare infrastructure is expected to boost pemphigus vulgaris market in the coming years. Diagnostic procedures are also undergoing a sea-change, which can be of great importance for the market.

Pemphigus Vulgaris Market Segmentation:
MRFR segmented the global pemphigus vulgaris market to have a closer peek at the market. This segmentation includes treatment, route of administration, and end-use.

Based on the treatment type, the pemphigus vulgaris market includes corticosteroids, biological therapies, immunosuppressants, and intravenous immunoglobulin (IVIG) therapy. The immunosuppressants has almost 31% share in the global pemphigus vulgaris market, and the corticosteroids segment is to follow with 28.6% share.
Based on the route of administration, the pemphigus vulgaris market includes intravenous, subcutaneous, and oral. The intravenous administration is the most-used process among various methods of drug administration. The segment had 40.6% of the global market share, in 2017.

By end-use, the pemphigus vulgaris market includes hospitals & clinics, specialty dermatology clinics, and research & academic laboratories. The hospitals and clinics segment had a valuation of USD 141 million in 2017 and is expected to showcase 8.2% CAGR during the review period. The specialty dermatology clinics segment has the potential to register 8.1% CAGR over the forecast period.

Pemphigus Vulgaris Market Regional Analysis:
Region-specific segmentation of the pemphigus vulgaris market, as conducted by MRFR, includes a detailed study of the Americas, Europe, Asia Pacific, and Rest-of-the-World (RoW).

The Americas market has the maximum market share. With 43.4% of the global pemphigus vulgaris market in 2017, the region is leading the market. Technological innovation and robust infrastructure are going to drive the regional market forward. The region is divided into North America and South America. North America is doing better with country-specific markets like the U.S., and Canada.

Europe is following the lead with 38.5% share. Presence of countries like France, the UK, Germany, and others are expected to take the regional market forward. These two regions are witnessing such a surge in the number of people affected with the disease due to the growing number of people of Mediterranean descent. The Americas has the potential to climb up to a valuation of USD 297.41 million by 2027 at a CAGR of 8.1% over the assessment period. The European pemphigus vulgaris market to surpass a valuation of USD 261.37 million by 2027.


Pemphigus Vulgaris Market Competitive Landscape:
Several players in the global pemphigus vulgaris market are showing keen interest in taking their prospect ahead by implementing strategic moves. MRFR, in their latest report on the market, profiled several companies like Biogen Inc. (U.S.), Almirall SA (Spain), F. Hoffman-La Roche (Switzerland), Argenx SE (Belgium), Syntimmune (India), Sanofi (France), Pfizer Inc. (U.S.), Janssen Global Services LLC (U.S.), Novartis AG (Switzerland), and Principia Biopharma (U.S.). The report tracks their recent moves to get a good grasp over the market trends.
Posted by at No comments:
Labels:

Cell Isolation/Cell Separation Market 2020 Global Trends, Share, Industry Size, Growth, Opportunities, And Industry Forecast

Cell Isolation Market – Overview
Cell Isolation/Cell Separation Market size is expected to register a CAGR of 17.1% during the forecast period and reach USD 10,567.4 million by 2023.

The escalated level of emphasis on biotechnological research is encouraging the growth of cell isolation market. Reports that appraise the healthcare industry have been made accessible by Market Research Future, which produces reports on several industry verticals that examine the market growth and prospects.

The cost-effective benefits harnessed from the use of cell isolation techniques is expected to be a major factor motivating the development of the market in the coming years. The use of cell isolation for applications such as microarray hybridization, biomarker identification, and genetic analysis is expected to bolster the market progress in the approaching period.

Cell Isolation Market Segmental Analysis
The segmental analysis of the cell isolation market is segmented on the basis of cell type, product, end-user, technique, application, and region.  Based on the product, the cell isolation market is segmented into instruments and consumables. The segmentation of the cell isolation market report based on cell type comprises of animal cells and human cells. Based on the technique, the cell isolation market is segmented into surface marker-based cell isolation, centrifugation-based cell isolation, and filtration-based cell isolation. Based on application, the market for cell isolation is segmented into cancer research, biomolecule isolation, stem cell research, in-vitro diagnostics, tissue regeneration, and therapeutics. On the basis of end-user, the cell isolation market is segmented into biotechnology & biopharmaceutical companies, research laboratories & institutes, cell banks, and hospitals & diagnostic laboratories. On the basis of regions, the cell isolation market is segmented into the Americas, Europe, Asia Pacific, Africa, and the Middle East.

Cell Isolation Market Regional Analysis     
The regional examination of the cell isolation market comprises of regions such as the Americas, Europe, Asia Pacific, Africa, and the Middle East. The Americas region is in charge of the principal segment of the overall market presently. The growing incidence of chronic diseases, mounting expenses in R&D activities directed by healthcare organizations and government bodies along with the growing demand for proper treatment options, are motivating the regional market. Additionally, the region is also technologically progressive, and emerging countries in the region possess considerably established healthcare sectors which are at the forefront of pioneering research and technology. In the meantime, the Asia Pacific is likely to improve at a vigorous CAGR of 17.7% throughout the forecast period. The incidence of an enormous population with a substantial patient pool as compared to other regions and the continuing initiatives presented by the government to restructure the healthcare sector is projected to motivate the market. Nations such as Singapore, Australia, and Malaysia, among others, are the greatest lucrative markets in the region and include large patient pools, increased amount of geriatric population and quickly improving healthcare facilities. The market is controlled by the absence of appropriate capital, among other factors. Though, a supportive regulatory framework concerning biotechnology research is anticipated to lift market growth.


Cell Isolation Market Competitive Analysis
The growth of the market is influenced by the presence of factors that are stimulating the growth of the market. The need to create a sustainable competitive advantage has accelerated the progress of the market in the forecast period. The diversified consumer tastes and trends in the market are anticipated to lead to an escalated development rate in the market. The use of strategic tools to further the development of the market in the coming years. The competitors have adopted diversified plans to increase their chances for success in the market. The creation of great competitive advantages is expected to aid in the development of the market. A substantial ascent in the number of promoters in the market is anticipated to shape a beneficial state of activities for the growth of the market in the forecasted period. The access to vital planned prospects imperative to the resultant stabilization of inflation is likely to produce a promising option for advancement in the forthcoming years.

The central players shaping the cell isolation market comprise of Becton, Dickinson & Company, STEMCELL Technologies, GE Healthcare, Beckman Coulter, Merck KGaA., TERUMO Corporation, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Miltenyi Biotec, F.Hoffman-La Roche AG, and others.
Posted by at No comments:
Labels:

Tuesday, 5 May 2020

Healthcare Artificial Intelligence (AI) Market: Business Strategies And Future Growth Study

Artificial Intelligence in Healthcare Market Competitive Landscape
In the global market AI healthcare companies are marked as Koninklijke Philips N.V., IBM Corporation, Intel Corporation, NVIDIA Corporation, Deep Genomics, Inc., Microsoft Corporation, Siemens Healthineers GmbH, General Electric Company, CloudMedx Inc., Google, Inc., General Vision, Inc., Johnson & Johnson, Medtronic Plc., and Stryker Corporation.

Artificial Intelligence in Healthcare Market Analysis
As per a report published by Market Research Future (MRFR), the global healthcare artificial intelligence market is likely to capture an impressive CAGR of 51.9% over the forecast period 2018 to 2023. Additionally, the potential of artificial intelligence has dramatically transformed the healthcare market since the past few decades. Technological progress, coupled with the associated algorithm is driving the market growth to a considerable extent.

Artificial intelligence (AI) finds wide application in healthcare research activities. It helps in identifying chronic disorders, managing them with utmost importance, discovering drugs, and delivering required health services. AI systems and applications offer new avenues and efficiencies which enable healthcare researchers and professionals to enhance their performance and improve the lives of the patients. The algorithms used in Artificial intelligence helps practitioners in analyzing complicated research information. The potential of the algorithm to interpret the given data in a meaningful way aids in the manufacturing of precision drugs, predicting the outcome of a medical scenario, and drug discovery.

Artificial Intelligence in Healthcare Market Segmentation
AI in Healthcare Market Statistics has been segmented based on application, component, end user, and technology.
By application, the healthcare artificial intelligence market has been segmented into robot-assisted surgery, virtual nursing assistant, clinical trial, dosage error reduction, automated image diagnosis, and preliminary diagnosis.
By component, the healthcare artificial intelligence market has been segmented into services, software, and hardware.

By end user, the healthcare artificial intelligence market has been segmented into diagnostic centers & hospital, biotechnology & pharmaceutical companies, and research & academic laboratories.

By technology, the healthcare artificial intelligence market has been segmented into natural language processing, querying method, and machine learning.

Artificial Intelligence in Healthcare Market Regional Analysis
Based on region, the global healthcare AI market has been segmented into Asia-Pacific, Europe, the Americas, and the Middle East and Africa. The Americas held the largest share of the global healthcare AI market. The region is expected to lead the global healthcare AI market in the upcoming years. The growth of the Americas can be attributed to the rapidly expanding biotechnology sector, well-developed healthcare infrastructure, and the progressive instances of robotic surgery. The Massachusetts Biotechnology Council report 2016 states that the prevalence of biotechnology companies has crossed 250 within Cambridge and Boston. It has also revealed that in 2018, biotech job opportunities witnessed a sharp increase by 6.7% as compared to 2015. In 2017, Europe held the second-largest share in the global healthcare AI market. The growth in this market is owing to the wide-ranging research & development activities conducted in the healthcare domain. 


The rapid adoption of technology, along with the surging level of investments by the government also plays a major role in propelling the market growth in this region. A report published by the Nuffield Council on Bioethics stated that in 2018, a deal of USD 1.2 billion was signed between the industry players and the UK government. The deal included an investment of USD 371 million in AI research. Asia-Pacific is projected to record a healthy CAGR over the forecast period. The development in this region is mostly due to the growing demand for therapeutic cure of chronic ailments. Besides, the rapidly evolving healthcare sector in this region acts as a significant factor for driving the healthcare AI market. The Middle East and Africa market is estimated to witness slow development owing to lack of awareness, strict government regulations, and less exposure to healthcare services.
Posted by at 1 comment:
Labels:

Atorvastatin API Market To Witness A Pronounce Growth Of 3.34% CAGR By 2023: Global Size, Share, Sales, And Regional Analysis Report 2020

Market Research Future has Published a Cooked Research Report on the Global Atorvastatin API Market. MRFR Provides Atorvastatin API Market Overview, Regional Analysis, Segmentation, Top Company Profile

Atorvastatin API Market – Overview
The increasing obesity rates, coupled with an increased incidence of cholesterol problems, is increasing the demand for atorvastatin. Reports that review the healthcare industry have been presented by Market Research Future, which produces reports on industry verticals that appraise the market expansion and prospects. The Atorvastatin API Market Report is positioned to achieve a CAGR of 3.34% while earning revenues worth USD 4,25,804.16 thousand by 2023.

The need to regulate vital cardiovascular functions is the primary factor fuelling the atorvastatin API market globally. The surging use of atorvastatin to treat cardiovascular diseases is fuelling the development of the market for atorvastatin APIs. The market is expected to be motivated market expansions that are expected to be carried out by industry leaders in the approaching CAGR in the forecast period.

Atorvastatin API Market Segmental Analysis
The segmental study of the atorvastatin API market is carried out on the basis of application and region. The application basis of segmenting the atorvastatin API market is carried out on the basis of hypertriglyceridemia, hypercholesterolemia, dyslipidemia, and others. The hypercholesterolemia segment is anticipated to control the market to touch USD 2,10,753.23 thousand by the end of 2023. The high incidence of hypercholesterolemia is anticipated to initiate positive market growth. Also, the segment is expected to display the uppermost CAGR of 4.09% from 2018 to 2023. The regions counted in the atorvastatin API market are Europe, North America, Asia Pacific, the Middle East, and Africa.

Detailed Regional Analysis   
The regional review of the atorvastatin API market includes region such as Europe, North America, Asia Pacific, the Middle East, and Africa. The North American region was in charge of the largest market portion of 40.64% in 2017, and the regional market is expected to record a CAGR of 3.10 % through the forecast period. Moreover, the Asia Pacific is projected to utilize the fastest CAGR. The Chinese regional market is projected to display the maximum development rate of 5.86 % during the forecast period from 2018 to 2023. The European regional market is appraised to surpass USD 1,31,094.04 thousand by the year 2023. The high prevalence of mixed dyslipidemia and hypercholesterolemia are impelling the growth of the Atorvastatin API market in the region. France is the key supplier to the development of the regional market, followed by the UK.

Atorvastatin API Market Competitive Analysis
The trade-offs between the resources needed to manage the challenges in the market are being carried out increasingly to improve the market’s scope for development. The need to establish cost-benefit analysis is leading to enhanced product development in the market. The state of the assets is also thoroughly examined to determine whether an investment is required to maintain the marketing system in its existing, unimproved state. The market competitors are also carefully scrutinizing whether intervention is required to ensure efficient use of society’s resources. The development of the alternative courses of action in terms of both their expenses and consequences are steering the growth of the market. The market players are concentrating on strategies that lead to the highest degree of development in the market. They are also making the most effective use of resources which is dependent on an effective appraisal and planning process.


The outstanding leaders in the Atorvastatin API Market globally are Jubilant Life Sciences Ltd (India), Dr. Reddy’s Laboratories Ltd (India), Teva Pharmaceutical Industries Ltd (Israel), Morepen Laboratories Ltd (India), Sun Pharmaceutical Industries Ltd (India), Ind-Swift Labs Ltd (India), Anuh Pharma Ltd (India), Zhejiang Hisun Pharmaceutical Co Ltd (China), Centrient Pharmaceuticals (The Netherlands) and Cadila Pharmaceuticals (India).
Posted by at No comments:
Labels:

Healthcare Fraud Detection Market Business Opportunities, Target Audience, Statistics And Growth Potential

Healthcare Fraud Detection Market Outlook
Market Research Future (MRFR) has launched a new report on the global healthcare fraud detection market and has indicated that the healthcare fraud detection market trends is expected to register a CAGR of 28.83% to reach USD 3,787.68 Million by 2024.

The problem of fraudulent claims is intensifying in the healthcare sector and is a burden to society. Healthcare fraud detection generally involves account auditing and detective investigation for fraudulent activities. Some of the common healthcare fraud cases include billing for services that are not provided, separate billing for laboratory tests performed together to claim higher reimbursements, usage of healthcare cards by others, and many more. Such fraudulent activities are detected by using statistical, analytical, deep learning, and predictive modeling methods. The healthcare sector is witnessing more payment breaches than ever before due to which the adoption of healthcare fraud detection solutions has gained enormous importance. 

Misinterpretation, as well as intentional deceit in facts related to payments, have given rise to the need for robust fraud detection systems. Various healthcare organizations across the globe are augmenting their anti-fraud initiatives with proprietary detection technologies. Deployment of such solutions helps to reduce common falsification activities such as multiple claims filed by different providers for same patient, intentional misrepresentation of dates, duration, frequency, or description of services provided. As greater number of patients are seeking healthcare insurance, the chance of healthcare fraudulent activities are also increasing manifold.

On the other hand, despite various benefits aligned with fraud detection solutions, their implementation is restricted by time-consuming deployment process and the need for frequent software upgrades.

Healthcare Fraud Detection Market Segmentation
The healthcare fraud detection market has been segmented based on component, delivery model, type, application, end-user.

By component, the healthcare fraud detection market has been segmented into services and software.
By delivery model, the healthcare fraud detection market has been segmented into on-premise delivery models and on-demand delivery models.

By type, the healthcare fraud detection market has been segmented into descriptive analytics, predictive analytics, and prescriptive analytics. Descriptive analytics is the base for effective application of predictive or prescriptive analytics and the descriptive analytics segment is thus anticipated to lead the market.  

By application, the healthcare fraud detection market has been segmented into insurance claims review and payment integrity. The insurance claims review segment has been further segmented into post-payment review and prepayment review.

By end-user, the healthcare fraud detection market has been segmented into private insurance payers, government agencies, employers, and others. 

Healthcare Fraud Detection Market Regional Analysis
Region-wise, the healthcare fraud detection market has been segmented into the Americas, the Middle East & Africa (MEA), Europe, and Asia Pacific (APAC).

The Americas is governing the global fraud detection market. The rising number of fraudulent activities in the region, along with government initiatives to curb frauds in the healthcare sector is boosting the growth of the market. Increased spending on healthcare IT, the presence of major players in the region, and technological advancements in the region are other driving factors.

The spiraling rise in the number of healthcare forgery and corruption incidents in Europe has significantly driven the healthcare fraud detection market in the region. The governments in the region are endeavoring to integrate IT into the healthcare infrastructure and are outlaying significant amounts on the same.

APAC healthcare fraud detection market is slated to expand at a torrid pace over the forecast period. Swiftly developing healthcare sector, surging incidence rate of cybercrimes in the region, and increased investment in healthcare IT are propelling the growth of the market in APAC.

The MEA market is likely to capture the least share of the market over the forecast period. The majority of the market growth is anticipated to be cornered towards the Middle East, where investments are being poured in for the development of the healthcare sector due to rising incidences of health insurance frauds.


Healthcare Fraud Detection Market Competitive Landscape
International Business Machines Corporation (IBM), Wipro, HCL Technologies, SAS Institute, Northrop Grumman, McKesson, Fair Isaac, Scio Health Analytics, Pondera Solutions, Conduent, Optum, Verscend Technologies, LexisNexis, DXC Technology, and CGI Group are the eminent players in the healthcare fraud detection market.
Posted by at No comments:
Labels:

Cell Therapy Market Segmentation, Development Trends, Revenue, In-Depth Analysis With Specifications, Outstanding Growth

Cell Therapy Market Overview
Global cell therapy market size is expected to exhibit a CAGR of 22.36% over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR).

Cell Therapy Market Competitive Analysis:
Leading players in the global cell therapy industry include AlloCure, Arteriocyte Medical Systems, Athersys Inc., Baxter Healthcare Corporation, Bone Therapeutics, Celgene Corporation, Cell Medica, Cellerant Therapeutics, Fibrocell, and Forticell Bioscience.

In August 2019, MIT researchers came up with a method to improve the outcomes of a CAR T-cell therapy for oncological applications. Using a vaccine to boost the number of anti-cancerous T cells, the new method has been shown to be effective against solid tumors.

Cell Therapy Market Segmentation:
The global cell therapy market is segmented on the basis of type, product, technique, technology, cell source, application, end use, and region.
By type, the global cell therapy market is segmented into autologous and allogeneic. The autologous segment is likely to dominate the global cell therapy market over the forecast period.
By product, the global cell therapy market is segmented into consumables, equipment, and software and other services.
By technique, the global cell therapy market is segmented into stem cell therapy, cell vaccine, adoptive cell transfer, fibroblast cell therapy, and chondrocyte cell therapy.
By technology, the global cell therapy market is segmented into viral vector technology, cell immortalization technology, and genome editing technology.
By cell source, the market is segmented into bone marrow, adipose tissue, and umbilical cord blood-derived cells.
By application, the global market is segmented into oncology, CVD, orthopaedic, and wound healing.
By end use, the global cell therapy market is segmented into hospitals and clinics, regenerative medicine centers, and research institutes.

Cell Therapy Market Regional Analysis:
The global cell therapy market is likely to be dominated by the Americas regional segment over the forecast period due to the increasing demand for cell therapy in the highly advanced healthcare sector in North America. North America is likely to dominate the global cell therapy market over the forecast period due to the growing development in the field of cell therapy and the increasing demand for advanced remedial solutions such as cell therapy. The presence of leading players in the cell therapy market in the region is also a major driver for the cell therapy market in North America and is likely to propel smooth growth of the market in the region over the forecast period.

The Americas region accounted for a dominant 37.6% of the global cell therapy market in 2017 and is expected to exhibit a robust 21.45% CAGR over the forecast period.

Europe is also likely to exhibit smooth growth in the global cell therapy market in the coming years due to the increasing demand for advanced healthcare methodologies such as cell therapy. Cell therapy requires the use of highly advanced genetic engineering processes in order to make the full use of the technology’s potential, leading to the presence of several leading market players in the region to be manifested as a major driver for the cell therapy market in Europe. The Europe market for cell therapy is expected to rise to USD 6,357.79 million by 2023, exhibiting rapid progress due to the growing healthcare expenditure in the region and the presence of a strong healthcare infrastructure.


Asia Pacific is also likely to exhibit smooth growth in the cell therapy market over the forecast period due to the growing demand for the highly advanced medical procedures involved in cell therapy in leading countries such as China, Japan, South Korea, and India. These countries have been the leading lights for the healthcare sector in Asia Pacific and are likely to host increasing technological advancements in the healthcare sector in the coming years, enabling smooth progress of advanced medical therapies such as cell therapy.

The Middle East and Africa is not likely to account for a major share in the global cell therapy market over the forecast period due to the lack of spending capacity among consumers in the region.
Posted by at No comments:
Labels:

Healthcare CRM Market 2020 Global Analysis, Segments, Size, Share, Industry Development And Recent Trends

Healthcare CRM Market Overview
A healthcare customer relationship management (CRM) tool aids in an efficient approach for interaction management with patients. It also enables the management, coordination, and automation of various business processes. A healthcare customer relationship management analyzes and segments patient populations helping in the measurement of the success of engagement tactics.

Global healthcare CRM market size is estimated to witness a 13.4% CAGR throughout the forecast period of 2019-2025. A rapid ascension in the adoption of customer relationship management software in the healthcare sector can be consequential to numerous benefits provided by a CRM system. Comfortable customer data arrangement and simple interactions are some of the benefits of a CRM solution driving a healthcare CRM solution market. Further, the simplification of many business processes, including customer service and support, marketing, sales, and digital marketing is promoting the adoption of CRM systems in the healthcare sector.

Moreover, a growing emphasis on patient engagement and rising demand for structured data are fueling the healthcare CRM market to a great extent. Increasing penetration of automation of various processes with the use of software and solutions is pushing the healthcare sector to keep up with the trend by adopting advanced CRM systems during the conjectured time period.

Even though numerous factors are working in favor of the healthcare CRM market, high cost and complexity relating to CRM are posing as hindrances in the growth rate of the market. Additionally, raising concerns regarding data security is creating hesitation in the adoption of CRM systems in the healthcare sector through the assessment period.

Healthcare CRM Market Segmentation
MRFR segments the global healthcare CRM market on the basis of components, deployment model, functionality, end-users, and region. Based on component, the healthcare CRM market is segmented into services and software. Among these segments, the services segment is projected to expand at the highest CAGR owing to the vital role of service providers in the use of CRM solutions for healthcare.

Based on deployment model, the global healthcare CRM market is segmented into on-premise model and web/cloud-based model. The web/cloud-based model is further sub-segmented into public cloud, hybrid cloud, and private cloud. The web/cloud-based model is expected to showcase significant growth during the forecast period.

Based on functionality, the global healthcare CRM market is segmented into customer service and support, marketing, sales, and digital marketing. The segmentation based on end-users includes healthcare providers, healthcare payers, and life science industry.

Healthcare CRM Market Regional Analysis
Based on geography, the global healthcare CRM market is segmented into the Americas, Asia Pacific, Europe, and the Middle East & Africa. The Americas are further segmented into North America and South America. Americas are estimated to spearhead the healthcare CRM market during the prediction period. Such market command can be accredited to the mounting clinical and R&D budgets by governments in both the sub-segments to encourage the adoption of healthcare IT and electronic health record (EHR). Conferring to the U.S. Department of Health and Human Services, in 2015, around 84% of hospitals were observed adopting a basic HER system in the U.S.  

Europe is projected to grasp the second largest share in the global healthcare CRM market. This rate of growth can be attributed to the excellent network and IT development witnessed by the region in recent years. Also, a growing effort of CRM providers to develop and commercial artificial intelligence and analytics-powered innovative CRM solutions is fueling growth in the regional market.

Asia Pacific is estimated to surge at the fastest rate during the forecast period. Such growth can be owed to the improving quality of healthcare systems, increasing introduction of supportive government initiatives, and rising medical tourism market in the region.


Healthcare CRM Market Key Players
Some of the notable players in the healthcare CRM market include Saleforce.Com, Inc., Oracle, Microsoft, IBM, SAP SE, Influence Health, Inc., Accenture, Healthgrades, Infor, Inc., Amdocs Ltd., Anthelio Healthcare Solutions, AllScripts Healthcare Solutions Inc., and NetSuite.
Posted by at No comments:
Labels:

Biological Safety Cabinet Market Trends, Industry Forecast and Applications

Biological Safety Cabinet Market Analysis  
Global biologics safety testing market growth is predicted to expand at a 13.6% CAGR between 2018-2023, reveals the new Market Research Future (MRFR) report. Biological safety testing is conducted to ensure both the non-contamination and safety of biopharmaceuticals and vaccines and also comply with its regulations. Bioburden tests, adventitious agent detection tests, residual host contamination detection tests, cell line authentication & characterization tests, endotoxin tests, sterility tests, and others are some major biological tests. It is used in stem cell research, tissue & tissue-related products testing, cellular & gene therapy, blood & blood-related products testing, and vaccine & therapeutics development.  

Numerous factors are adding to the global biologics safety testing market growth. Such factors, as revealed by the recent MRFR report, include growing demand for biological products, growing biotech and pharmaceutical industry, rising number of innovative drug launches, and high prevalence and huge economic burden of various chronic diseases. Increasing research and development investment in life science and favorable government support are also adding market growth.  

On the contrary, high investment costs related to biological safety cabinets, time-consuming approval process, stringent government regulations, and scarcity of skilled professionals to conduct biological safety testing are factors that may limit the biologics safety testing market growth during the forecast period.  

Biological Safety Cabinet Market Segmentation 
The Market Research Future Report provides an inclusive segmental analysis of the biologics safety testing market based on application, test type, and product.  

By product, the biologics safety testing market is segmented into instruments, services, and kits & reagents. Of these, kits and reagents will lead the market over the forecast period. 

By test type, the biologics safety testing market is segmented into bioburden tests, adventitious agent detection tests, residual host contamination detection tests, cell line authentication & characterization tests, endotoxin tests, sterility tests, and others. Of these, endotoxin tests will dominate the market over the forecast period for increasing drug launches and rising disease prevalence. This testing is used in drug development, gene therapy, vaccine testing, monoclonal antibody testing, and cell therapy.  

By application, the biologics safety testing market has been segmented into stem cell research, tissue & tissue-related products testing, cellular & gene therapy, blood & blood-related products testing, and vaccine & therapeutics development. Of these, vaccine & therapeutics development will have a major share in the market over the forecast period for rising company investments to develop vaccines, growing initiatives for immunization, and increasing prevalence of diseases.  

Biological Safety Cabinet Market Regional Analysis 
By region, the biologics safety testing market covers the growth opportunities and recent trends across Europe, the Americas, the Middle East & Africa (MEA), and the Asia Pacific (APAC). Of these, the Americas will command the largest share in the market over the forecast period. Factors adding to the biologics safety testing market growth in the region include growing demand for biological products, new product launches, presence of well-established players, and growing pharmaceutical and biotechnology industries. Additional factors adding market growth include favorable government initiatives, rising R&D spending, and advanced healthcare infrastructure.  
The global biologics safety testing market in Europe is predicted to hold the second-largest share during the forecast period for the growing biotech and pharma industry.  

The biologics safety testing market in the APAC region is predicted to grow at a quick pace during the forecast period for the burgeoning demand for biologics products.  

The biologics safety testing market in the MEA will have a small share over the forecast period. The Middle East will have major share for the presence of a well-established healthcare sector.  


Biological Safety Cabinet Market Key Players 
Leading players profiled in the global biologics safety testing market report include Eurofins Scientific, Avance Biosciences Inc., Cytovance Biologics, Inc., Wuxi Apptec, Thermo Fisher Scientific Inc, SGS S.A., Lonza Group Ltd., Sartorius AG, Charles River Laboratories, and Merck KGaA. 
Posted by at No comments:
Labels:
Subscribe to: Posts (Atom)